Journal
CIRCULATION RESEARCH
Volume 91, Issue 2, Pages 165-172Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.RES.0000028007.91385.EE
Keywords
adenosine receptors; ischemia; transgenic mice; heart
Funding
- NCRR NIH HHS [RR-11803] Funding Source: Medline
- NHLBI NIH HHS [HL-55757, HL-43151, R01 HL060051, R01 HL043151, R01 HL055757, HL-68088, HL-60051, R37 HL055757, R01 HL068088] Funding Source: Medline
Ask authors/readers for more resources
We used a genetic approach to determine whether increasing the level of A(3) adenosine receptors (A(3)ARs) expressed in the heart confers protection against ischemia without causing cardiac pathology. We generated mice carrying one (A(3)tg.1) or six (A(3)tg.6) copies of a transgene consisting of the cardiomyocyte-specific alpha-myosin heavy chain gene promoter and the A(3)AR cDNA. A(3)tg.1 and A(3)tg.6 mice expressed 12.7 +/- 3.15 and 66.3 +/- 9.4 fmol/mg of the high-affinity G protein-coupled form of the A(3)AR in the myocardium, respectively. Extensive morphological, histological, and functional analyses demonstrated that there were no apparent abnormalities in A(3)tg.1 transgenic mice compared with nontransgenic mice. In contrast, A(3)tg.6 mice exhibited dilated hearts, expression of markers of hypertrophy, bradycardia, hypotension, and systolic dysfunction. When A(3)tg mice were subjected to 30 minutes of coronary occlusion and 24 hours of reperfusion, infarct size was reduced approximate to30% in A(3)tg.1 mice and approximate to40% in A(3)tg.6 mice compared with nontransgenic littermates. The reduction in infarct size in the transgenic mice was not related to differences in risk region size, systemic hemodynamics, or body temperature, indicating that the cardioprotection was a result of increased A(3)AR signaling in the ischemic myocardium. The results demonstrate that low-level expression of A(3)ARs in the heart provides effective protection against ischemic injury without detectable adverse effects, whereas higher levels of A(3)AR expression lead to the development of a dilated cardiomyopathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available